A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
7/22/2025
AIMeetingNewsletterRefractive
Octane Examines Changing Refractive Surgery Landscape
The 2025 Octane Ophthalmology Tech Forum examined why lens-based procedures are gaining momentum at the expense of traditional refractive surgery. It also looked at the pivotal role that artificial...
7/22/2025
CataractEquipmentNewsletter
Alcon Aims to Extend Ultrasonic Phaco Dominance with Launch of Unity CS
Alcon launched the Unity VCS and CS machines in April at the annual meeting of the American Society of Cataract and Refractive Surgery, looking to continue its global dominance in the cataract mach...
7/22/2025
ChinaNewsletterRegulation
Chinese Companies Launch Wave of New Ophthalmic Products at Home
China’s ophthalmic market is riding a wave of new Chinese offerings, spurred on by policies promoting the locali-zation of medical products. New products from Chinese companies approved by the Nati...
7/22/2025
AcquisitionsDealsFundingNewsletter
Ophthalmic Venture Capital Continues to Bounce Back, Driven by Retinal Pharma
Venture capital investments accounted for 96 percent of ophthalmic deals in Q2-2025, with financing rounds totaling $590.7 million—the highest quarter since Q3-2023, when these transactions reached...
7/22/2025
AcquisitionsDealsNewsletterRetina
Alcon to Acquire LumiThera and Its Photobiomodulation Device for Dry AMD
Alcon announced July 7 that it intended to acquire LumiThera and its photobiomodulation (PBM) device that targets early and intermediate dry age-related macular degeneration (AMD). No financial det...
7/22/2025
CataractIOLNewsletterPremiumSurgical
J&J Vision Launches Tecnis Odyssey PC-IOL in Europe, Middle East, and Canada
Johnson & Johnson Vision announced June 17 that it had rolled out the Tecnis Odyssey presbyopia-correcting intraocular lens (PC-IOL) in Europe, the Middle East, and Canada. The Odyssey had previous...
7/22/2025
CataractGlaucomaLaserNewsletterRegulation
Select US FDA Approvals and Clearances in June 2025
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in June 2025, according to the agency’s database. Zeiss received clearance for its Micor 700 syst...
7/22/2025
DealsNewsletterRetina
Harrow Secures US Rights to Retinal Biosimilars Byooviz and Opuviz
Harrow announced July 17 that it had secured exclusive US commercial rights to Samsung Bioepis’ FDA-approved ophthalmology biosimilars—Byooviz (ranibizumab-nuna) and Opuviz (aflibercept-yszy). No f...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.